Actively Recruiting

Age: 55Years +
All Genders
NCT06906003

Visual Rehabilitation and Depression in Visually Impaired Patients with AMD

Led by Fondazione G.B. Bietti, IRCCS · Updated on 2025-04-02

22

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

F

Fondazione G.B. Bietti, IRCCS

Lead Sponsor

S

Sant'Alessio - Margherita di Savoia

Collaborating Sponsor

AI-Summary

What this Trial Is About

Purpose: The aim of this study is to evaluate the impact of visual rehabilitation in visually impaired patients with advanced AMD by the use of questionnaires on the anxiety and depression status. Study design: prospective observational study. The study is carried out at the IRCCS Fondazione G.B.Bietti and at the UO Visual Rehabilitation, S. Alessio - Margherita di Savoia. Study procedures: Visit 1 (screening visit, at IRCCS Fondazione Bietti) After signing the informed consent, all patients received a complete ophthalmological examination, non-invasive diagnostic tests as optical coherence tomography, autofluorescence and microperimetry, and have to complete the questionnaires on the state of anxiety and depression (GAD-7 and PHQ-9). Visit 2 (at the Sant'Alessio Institute) for a 60-day visual rehabilitation program scheduled in 5 group meetings. Visit 3 (end-of-study visit, at IRCCS Fondazione G.B. Bietti) complete ophthalmological examination, as per clinical practice, non-invasive diagnostic tests such as microperimetry, optical coherence tomography and autofluorescence and administration of the Patient Health Questionnaire-9 (PHQ-9) questionnaires for depression and the General Anxiety Disorder (GAD-7) questionnaires for anxiety.

CONDITIONS

Official Title

Visual Rehabilitation and Depression in Visually Impaired Patients with AMD

Who Can Participate

Age: 55Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 55 years or older
  • Moderate to severe visual impairment (best-corrected visual acuity between 1/10 and 2/10)
  • Diagnosis of advanced non-exudative age-related macular degeneration (AMD)
  • Provided informed consent before starting the study
  • Ability to understand and willingness to follow study instructions and procedures
Not Eligible

You will not qualify if you...

  • Visual impairment caused by other eye diseases
  • Mild visual impairment or partial or total blindness
  • Exudative age-related macular degeneration currently treated with intravitreal drugs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCCS Fondazione G.B.Bietti

Rome, Italy, Italy, 00184

Actively Recruiting

Loading map...

Research Team

E

Eliana Costanzo, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here